Pharmaceutical preparation "Bellalgin". Instructions for use

The pharmaceutical preparation "Bellalgin", the instruction for use informs, is a combined drug used in gastroenterology. One tablet contains two hundred and fifty milligrams of sodium metamizole, a similar amount of benzocaine, one hundred milligrams of sodium hydrogencarbonate, fifteen milligrams of belladonna extract (thick). These active components of the drug not only complement, but also enhance the effect of each other.

The drug "Bellalgin" (instructions for use includes this information) produces a moderate spasmolytic effect, can slow intestinal motility, reduce acidity and secretion of gastric juice, and also provide local anesthetic and analgesic effects. The drug is effective in eliminating pain in the epigastric region (also in the hyperacid state).

Medication "Bellalgin" instructions for use recommends the use of symptomatic short-term treatment for both adolescents over fourteen and adults suffering from intestinal colic and gastralgia, concomitant hyperacid gastritis, cholelithiasis, duodenal ulcers and / or stomach ulcers, spastic colitis. It is allowed to use the agent in the complex treatment.

The drug "Bellalgin". Instructions for use, dosage

This drug is taken orally (orally). Medication "Bellalgin" (tablets) should not be crushed, divided. At reception it is necessary to wash down it with a sufficient amount of pure water. It is recommended to apply the drug directly after eating. As a rule, this medication is not prescribed for long-term treatment. The duration of therapy and the optimal dosage are determined exclusively by the attending physician. Below are the averaged data:

When complaining of stomach pain, adult patients are shown one tablet at most three times a day. Do not take more than three tablets at a time and more than ten during the day.

It is noted that if the improvement of the patient's condition does not occur after three days from the beginning of treatment, he should be assigned a different scheme of therapy with the drug "Bellalgin".

Instructions for use inform that the considered pharmaceutical preparation can cause the development of the following undesirable consequences: agranulocytosis (extremely rare), leukopenia, tachycardia, persistent thirst, loose stool / constipation, dryness in the oral cavity. From the central nervous system is not excluded such violations as insomnia, headaches, dizziness, overexcitation or, conversely, weakness, apathy. In addition, the skin can develop a rash, itching, develop hives.

The medication in question is not prescribed for severe liver or kidney function failures, glaucoma, hematopoiesis, benign prostatic hyperplasia. The drug is also contraindicated in patients younger than fourteen and pregnant women.

An increase in the toxic effect produced by this medication has been established, when combined with oral contraceptives, nonsteroidal anti-inflammatory drugs and tricyclic antidepressants.

In case of an overdose, gastric lavage, symptomatic treatment, and the use of enterosorbents are indicated. Therapy should be performed under the supervision of a specialist (in a hospital).

The drug goes on sale in contour cell packs of ten in each.

Do not expose the tablets to direct sunlight.